Radiation boost tested to supercharge lung cancer treatment
NCT ID NCT03774732
Summary
This study is testing if adding targeted radiation to the standard first-line treatment (chemotherapy plus immunotherapy) helps people with advanced non-small cell lung cancer live longer. It aims to see if radiation can boost the immune system's ability to fight cancer throughout the body. The trial enrolled 327 adults with advanced lung cancer who are eligible for the standard drug combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Brest
Brest, France
-
CHU St Etienne
Saint-Etienne, France
-
CHU Sud de la Réunion
La Réunion, France
-
CHU de Nîmes
Nîmes, France
-
CHU de Toulouse Hôpital Larrey
Toulouse, France
-
Centre André DUTREIX
Dunkirk, France
-
Centre Antoine Lacassagne
Nice, France
-
Centre Azuréen De Cancérologie
Mougins, France
-
Centre Catalan d'Oncologie
Perpignan, France
-
Centre François Baclesse
Caen, France
-
Centre Frédéric JOLIOT
Rouen, France
-
Centre Georges Francois Leclerc
Dijon, France
-
Centre Henri Becquerel
Rouen, France
-
Centre Hospitalier Dr Jean-Eric TECHER
Calais, France
-
Centre Hospitalier Intercommunal De Creteil
Créteil, France
-
Centre Hospitalier Princesse Grace
Monaco, Monaco
-
Centre Hospitalier Universitaire De Caen - Hôpital Cote De Nacre
Caen, France
-
Centre Hospitalier William Morey
Chalon-sur-Saône, France
-
Centre Hospitalier de Dunkerque
Dunkirk, France
-
Centre Hospitalier de Montelimar
Montélimar, France
-
Centre Hospitalier des Pays de Morlaix
Morlaix, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Joliot Curie
Saint-Martin-Boulogne, France
-
Centre Marie Curie
Arras, France
-
Centre Marie Curie
Valence, France
-
Centre Oscar Lambret
Lille, France
-
Centre Paul Strauss
Strasbourg, France
-
Centre Pierre Curie
Beuvry, France
-
Centre de cancérologie du grand Montpellier-Clinique Clementville
Montpellier, France
-
Centre de radiothérapie et de cancérologie de Blois
La Chaussée-Saint-Victor, France
-
Centre hospitalier de Cannes Simone Veil
Cannes, France
-
Clinique Ambroise Pare
Beuvry, France
-
Clinique Chenieux
Limoges, 87039, France
-
Clinique Saint-Hilaire
Rouen, France
-
Fondation Hôpital Saint-Joseph
Paris, France
-
Gustave Roussy
Villejuif, France
-
Hopital Charles Nicolle
Rouen, France
-
Hopital Pitie Salpetriere
Paris, France
-
Hopital Tenon
Paris, France
-
Hôpital Européen Marseille
Marseille, France
-
Hôpital Privé Arnault Tzanck
Mougins, France
-
Hôpital Privé Arras Les Bonnettes
Arras, France
-
Hôpital Privé Clairval
Marseille, France
-
Hôpital Privé Drôme Ardèche
Valence, France
-
Hôpital Simone Veil Blois
Blois, France
-
Hôpital de Bicêtre
Le Kremlin-Bicêtre, France
-
Institut Bergonie
Bordeaux, France
-
Institut Claudius Regaud
Toulouse, France
-
Institut Curie - Hôpital René Huguenin
Saint-Cloud, France
-
Institut De Cancerologie De Lorraine
Vandœuvre-lès-Nancy, France
-
Institut Jean Godinot
Reims, France
-
Institut Sainte Catherine
Avignon, France
-
Institut de Cancérologie de Bourgogne
Chalon-sur-Saône, France
-
Institut de Cancérologie de Bourgogne
Dijon, France
-
Institut de Cancérologie de l'Ouest - Site Paul Papin
Angers, France
-
Polyclinique de l'Ormeau
Tarbes, France
-
Polyclinique du Parc Drevon
Dijon, France
-
Pôle départemental de Cancérologie Libérale 37
Chambray-lès-Tours, France
Conditions
Explore the condition pages connected to this study.